Brief: Synact Pharma: USPTO Issues Patent For Syntact's Resomelagon Crystal Form
04/03/2025 07:03
March 4 (Reuters) - SynAct Pharma AB SYNACT.ST: USPTO ISSUES PATENT FOR SYNTACT'S RESOMELAGON CRYSTAL FORM Source text: ID:nMFN5KrMY1 Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026